|
Volumn 435, Issue 7039, 2005, Pages 138-139
|
Chinese clinical trials: Consenting adults? Not necessarily...
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GEOGRAPHICAL REGIONS;
MARKETING;
PATIENT MONITORING;
CHINA;
CLINICAL TRIALS;
DRUG PRODUCTS;
DRUG DEVELOPMENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHINA;
CLINICAL RESEARCH;
CONTROL SYSTEM;
DRUG MARKETING;
DRUG SCREENING;
ETHICS;
GENE THERAPY;
GOOD CLINICAL PRACTICE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
PRIORITY JOURNAL;
SHORT SURVEY;
SQUAMOUS CELL CARCINOMA;
ARTICLE;
ASIAN;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
ETHNOLOGY;
FEMALE;
GOVERNMENT;
HUMAN;
INFORMED CONSENT;
INTERNATIONAL COOPERATION;
LEGAL ASPECT;
MEDICAL RESEARCH;
PATIENT ADVOCACY;
PATIENT SELECTION;
PRACTICE GUIDELINE;
STANDARD;
STATISTICS;
ASIA;
CHINA;
EASTERN HEMISPHERE;
EURASIA;
FAR EAST;
WORLD;
HUMAN IMMUNODEFICIENCY VIRUS;
CARRIER PROTEIN;
VGV 1 PROTEIN, CALF;
VGV-1 PROTEIN, CALF;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ASIAN CONTINENTAL ANCESTRY GROUP;
BIOMEDICAL RESEARCH;
CARRIER PROTEINS;
CHINA;
CLINICAL TRIALS;
FEDERAL GOVERNMENT;
FEMALE;
GUIDELINES;
HIV INFECTIONS;
HUMANS;
INFORMED CONSENT;
INTERNATIONALITY;
PATIENT ADVOCACY;
PATIENT SELECTION;
|
EID: 18744364460
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/435138a Document Type: Short Survey |
Times cited : (15)
|
References (0)
|